TrialScientific reports2025

Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma.

Daisaku Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.